Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy

Rheumatology

Volumn 48, Issue 6, 2009, Pages 676-679

  Labrador Horrillo, Moisés ^a   Martinez, Ma Angeles ^b   Selva O'Callaghan, Albert ^a   Delgado, Juan Francisco ^b   Martínez Gómez, Xavier ^c   Trallero Araguás, Ernesto ^a   Rodriguez Sanchez, Jose Luis ^b   Vilardell Tarrés, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Anti cyclic citrullinated peptide; Anti keratin antibodies; Arthritis; Autoimmunty; Idiopathic inflammatory myopathy; Inclusion body myositis; Myositis specific antibodies; Polymyositis; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KERATIN ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SYNTHETASE;

ADULT; AGE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAND RADIOGRAPHY; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MYOSITIS; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; AUTOANTIBODIES; BIOLOGICAL FACTORS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HAND; HUMANS; KERATINS; MALE; MIDDLE AGED; MYOSITIS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; STATISTICS, NONPARAMETRIC;

EID: 65849204034     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep065     Document Type: Article

References (27)

1. Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43: 155-63.
2. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2006;65:845-51.
3. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: Comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology 2002;41:809-14.
4. Sebbag M, Simon M, Vincent C et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9.
5. Girbal-Neuhauser E, Durieux JJ, Arnaud M et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro) filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
6. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
7. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089-93.
8. Takasaki Y, Yamanaka K, Takasaki C et al. Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 2004;14:367-75.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
11. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991;325:1487-98.
12. Griggs RC, Askanas V, DiMauro S et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
13. Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 2006;55:791-8.
14. Serre G, Vincent C, Fournie B, Lapeyre F, Soleilhavoup JP, Fournie A. Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects. Rev Rhum Mal Osteoartic 1986;53:607-14.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Lutteri L, Malaise M, Chapelle JP. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid artritis. Clinica Chimica Acta 2007;386:76-81.
17. Rantapää-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against citrullinated peptides and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
18. Vencovský J, Machácek S, Sedová L et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003;62:427-30.
19. van Rossum M, van Soesbergen R, de Kort S et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 2003;30:825-8.
20. Hoffman IEA, Peene I, Cebecauer L et al. Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis 2005;64:330-32.
21. Fusconi M, Vannini A, Dall'Aglio AC et al. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis. Aliment Pharmacol Ther 2005;22:951-5.
22. Gottenberg JE, Mignot S, Nicaise-Rolland P et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis 2005;64:114-17.
23. Vander Cruyssen B, Hoffman IE, Zmierczak H et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005;64:1145-9.
24. Elkayam O, Segal R, Lidgi M, Caspi D. Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 2006;65:1110-12.
25. Vannini A, Cheung K, Fusconi M et al. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis 2007;66:511-16.
26. Makrygiannakis D, af Klint E, Lundberg IE et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006;65:1219-22.
27. Wasko MC, Carlson GW, Tomaino MM, Oddis CV. Dermatomyositis with erosive arthropathy: Association with the anti-PL-7 antibody. J Rheumatol 1999;26:2693-4.